AptaTargets receives PRIME designation from the European Medicines Agency for ApTOLL in is... 06/03/2023 Healthcare Access to innovation Corporate AptaTargets has obtained priority medicines (PRIME) designation from the European Medicines Agency (EMA) for the... Partners - AptaTargets
Biolan receives the Award for “Best Start-Up trajectory” at the On Bizkaia 2023 Awards 02/03/2023 Healthcare Access to innovation Corporate The Lifetime Achievement award is given to a startup and a spinoff that have been supported by the regional programme... Partners - Biolan
Almirall opens the doors of its R&D centre to the biotech ZeClinics 27/02/2023 Healthcare Access to innovation Corporate Their incorporation into Almirall's R&D facilities is the first step in Almirall's plans to create a highly... Partners - Almirall
ORYZON Hosting Key Opinion Leader Webinar on Targeting Lysine Specific Demethylase 1 (LSD1... 22/02/2023 Healthcare Corporate Oryzon Genomics, announced today that it will host a virtual panel discussion, featuring Dr. Dyanna Phillips Domilici... Partners - Oryzon Genomics
#NewMember | "A leading organization in terms of innovation which promotes collaboration a... 22/02/2023 Healthcare Agrifood Industrial biotechnology Corporate Meet CEISA, our new member. We talked to Josep Tascón, CEO of the company. Partners
BCN HEALTH publishes a study reviewing economic evaluations and burden of disease studies ... 22/02/2023 Healthcare Access to innovation BCN HEALTH ha publicado el estudio 'Economic implications of endometriosis: A review' en la revista 'PharmacoEconomics' Partners - BCN Health
AseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere 16/02/2023 The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying... AseBio
AseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere 16/02/2023 Healthcare Climate change Agrifood International Financing The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying... AseBio
aptaTargets’ ApTOLL reduces mortality from 18% to 5% in a Phase 1b/2a trial in ischemic st... 09/02/2023 Healthcare Corporate ApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in acute ischemic stroke... Partners - AptaTargets
ORYZON to give updates on corporate progress in February-March 06/02/2023 Healthcare Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics... Partners - Oryzon Genomics
